Department of Allergy and Immunology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
Department of Dermatology, Huashan Hospital affiliated to Fudan University, Shanghai, China.
Photodermatol Photoimmunol Photomed. 2023 Jul;39(4):318-324. doi: 10.1111/phpp.12836. Epub 2022 Sep 29.
Ultraviolet radiation can aggravate facial erythema in atopic dermatitis (AD) patients.
To investigate the photobiological testing results of Chinese AD patients with refractory facial erythema.
We conducted a retrospective analysis of 82 AD patients with refractory facial erythema who visited our department during 2004-2021. All of them completed phototesting and photopatch testing.
82 patients were enrolled in the study, and 53 (64.6%) were between 18 and 30 years old. 51.2% (42/82) had positive phototesting results and were considered photosensitive AD (PhAD) patients. One-third of them were both allergic to ultraviolet A and ultraviolet B. 65.9% (54/82) suffered from photoallergic contact dermatitis. Chlorpromazine (50.7%), potassium dichromate (13.2%), and thimerosal (11.8%) were the top three common photoallergens. Overall, 86.3% of AD patients with refractory facial erythema had direct photoallergy or photocontact allergy. PhAD patients had fewer allergic comorbidities than the other group (p = .007). More non-PhAD patients (55.0%) suffered from AD at 2-14 years old (p = .015).
Photosensitivity contributes a lot to the facial lesions of AD patients, especially in their 20s. 86.3% of these patients had direct photoallergy or photocontact allergy. Therefore, AD patients with facial erythema should undergo phototesting and photopatch testing routinely.
紫外线辐射会加重特应性皮炎(AD)患者的面部红斑。
探讨中国特应性皮炎患者面部红斑的光生物测试结果。
我们对 2004 年至 2021 年期间来我院就诊的 82 例面部红斑难治性 AD 患者进行回顾性分析。所有患者均完成光试验和光斑贴试验。
共纳入 82 例患者,年龄 1830 岁者占 53.0%(42/82)。51.2%(42/82)患者光试验阳性,诊断为光敏感 AD(PhAD)患者,其中三分之一对 UVA 和 UVB 均过敏。65.9%(54/82)患者患有光接触性皮炎。氯丙嗪(50.7%)、重铬酸钾(13.2%)和硫柳汞(11.8%)为前三种常见光变应原。总体而言,86.3%的面部红斑难治性 AD 患者存在直接光过敏或光接触过敏。PhAD 患者的过敏合并症少于其他组(p=0.007)。更多的非 PhAD 患者(55.0%)在 214 岁时患有 AD(p=0.015)。
光敏性在 AD 患者的面部病变中起重要作用,尤其是在 20 多岁时。86.3%的患者存在直接光过敏或光接触过敏。因此,面部红斑的 AD 患者应常规进行光试验和光斑贴试验。